Isomorphic Labs
PulseAugur coverage of Isomorphic Labs — every cluster mentioning Isomorphic Labs across labs, papers, and developer communities, ranked by signal.
- founded by Alphabet Inc. 90%
- invested by Thrive Capital 90%
- spun off from Eli Lilly and Company 90%
- spun off from Novartis 90%
- affiliated with Alphabet Inc. 70%
- uses Novartis 70%
- invested by Alphabet Inc. 70%
- affiliated with Eli Lilly and Company 70%
- founded Novartis 70%
- founded by Thrive Capital 50%
- 2026-06-11 product_launch Isomorphic Labs is developing advanced protein modeling tools to accelerate AI-driven drug discovery. source
- 2026-05-27 funding Isomorphic Labs secured $2.1 billion in Series B funding led by Thrive Capital to accelerate its AI drug discovery efforts. source
- 2026-05-13 funding Isomorphic Labs secured $2.1 billion in Series B funding. source
- 2026-05-12 funding Isomorphic Labs secured $2.1 billion in Series B funding.
- 2026-05-12 funding Isomorphic Labs raised $2.1 billion in a Series B funding round.
- 2026-04-24 funding Isomorphic Labs closed a $2.1 billion Series B funding round led by Thrive Capital. source
4 day(s) with sentiment data
-
Google DeepMind Loses Top AI Talent to OpenAI and Anthropic
Several high-profile researchers have departed Google DeepMind, sparking concerns about Alphabet's competitive edge in the AI race. Notable exits include Noam Shazeer, who is joining OpenAI after previously criticizing …
-
Alphabet's algorithm crash highlights AI's lack of oversight and market impact
An algorithm developed by Alphabet, designed for "dark engagement" and the propagation of "fake narratives," has demonstrated a lack of human oversight. This system incorrectly flagged real economic data as conspiracy t…
-
AI-DNA startup Radical Numerics raises $50M seed funding
Radical Numerics, a startup founded by researchers who developed AI models for DNA generation, has secured $50 million in seed funding. The company aims to revolutionize biology by teaching AI to understand and generate…
-
Isomorphic Labs advances AI drug discovery with new tools
Isomorphic Labs, a spinout from Google DeepMind, is heavily investing in AI for drug discovery. The company is developing sophisticated protein modeling tools, leveraging Nobel Prize-winning research. These advancements…
-
Google DeepMind spinoff Isomorphic Labs advances AI drug discovery
Isomorphic Labs, a Google DeepMind spinoff, is advancing AI-driven drug discovery by developing new computational systems. Their Isomorphic Drug Design Engine (IsoDDE) builds upon AlphaFold's protein structure predictio…
-
AI drug discovery leaders warn U.S. funding cuts risk falling behind
Leaders in AI drug discovery are warning that cuts to U.S. health funding could cause the nation to fall behind global competitors. Experts at Fortune Brainstorm Tech emphasized that now is a critical time to invest in …
-
Biohub releases protein model; OpenAI Foundation pledges $250M for AI disruption
Biohub, a nonprofit backed by Mark Zuckerberg and Priscilla Chan, has released a comprehensive 'world model of protein biology' utilizing advanced Evolutionary Scale Models, including ESMFold2. This open-source stack ai…
-
Demis Hassabis' Isomorphic Labs raises $2.1B for AI drug discovery
Isomorphic Labs, an AI drug discovery startup founded by Demis Hassabis, has secured $2.1 billion in Series B funding led by Thrive Capital. The company plans to use the new capital to scale its compute resources, gener…
-
Google I/O 2026: AI agents, new web standards, and hardware unveiled
Google I/O 2026 showcased a significant expansion of AI capabilities across its services, moving beyond chatbots to focus on autonomous agents and background automation. Key announcements included the Gemini 3.5 Flash m…
-
Genesis AI partners with Incyte in $120M drug discovery deal
Genesis Molecular AI has secured a significant partnership with Incyte, a global biotech company, valued at $120 million. This deal includes $80 million in upfront cash and a $40 million equity investment, with potentia…
-
OpenAI launches GPT Realtime 2; Anthropic expands Claude for Legal
OpenAI has launched new voice intelligence features, including GPT Realtime 2 powered by GPT-5, offering real-time translation and transcription with an emphasis on reduced latency and larger context windows. Anthropic …
-
Isomorphic Labs and Anduril raise billions, fueled by AI advancements
Isomorphic Labs, an AI-driven drug discovery company, and Anduril, a defense technology firm, have both recently secured significant funding rounds. Isomorphic raised $2.1 billion in Series B funding, while Anduril clos…
-
Isomorphic Labs eyes $2B+ funding as Sinovac Biotech posts modest sales gain amid losses
Isomorphic Labs, an AI-driven drug discovery company spun out of Google DeepMind, is reportedly in advanced talks to raise over $2 billion in a new funding round. Thrive Capital, which led Isomorphic Labs' initial fundi…
-
Google DeepMind spinoff Isomorphic Labs raises $2.1B for AI drug trials
Isomorphic Labs, an AI-driven drug discovery company spun out of Google DeepMind, has secured over $2 billion in a Series B funding round. The substantial investment, led by Thrive Capital, will be used to expand its pr…
-
Google DeepMind's AlphaFold revolutionizes biology, accelerating drug discovery and research
Google DeepMind's AlphaFold system has significantly accelerated biological research over the past five years, being cited in over 35,000 papers and incorporated into the methodology of more than 200,000 others. Researc…